ConductScience.org, home

Paper14612901

The relationship between T-lymphocyte infiltration, stage, tumour grade and survival in patients undergoing curative surgery for renal cell cancer.

Bromwich EJ and 6 others. Br J Cancer, 2003. Cited by 136 papers, by iCite.

Cite this record

ConductScience Library. The relationship between T-lymphocyte infiltration, stage, tumour grade and survival in patients undergoing curative surgery for renal cell cancer. Papers, record 14612901. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/14612901

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The relationship between T-lymphocyte infiltration, stage, tumour grade and survival in patients undergoing curative surgery for renal cell cancer.
PubMed
Journal
Br J Cancer
PubMed
Year
2003
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
136
iCite
Relative citation ratio, by iCite
2.33
iCite
Revised in PubMed
2022-04-09
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Bromwich EJE J
2McArdle PAP A
3Canna KK
4McMillan DCD C
5McNicol AMA-M
6Brown MM
7Aitchison MM

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Carcinoma, Renal CellMajor topic
Kidney NeoplasmsMajor topic
Neoplasm StagingMajor topic
T-LymphocytesMajor topic
Aged
Cohort Studies
Female
Humans
Immunohistochemistry
Male
Middle Aged
Survival Analysis
Treatment Outcome

Source PubMed

Download CSV of topics

References6

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
112681265Renal-cell carcinoma: tumour markers, T-cell epitopes, and potential for new therapies.Lancet Oncol2003https://conductscience.org/library/papers/12681265PubMed
29307205TNM staging of renal cell carcinoma: Workgroup No. 3. Union International Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC).Cancer1997https://conductscience.org/library/papers/9307205PubMed
39721846CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer.Cancer Res1998https://conductscience.org/library/papers/9721846PubMed
411431351Proliferative activity of intratumoral CD8(+) T-lymphocytes as a prognostic factor in human renal cell carcinoma: clinicopathologic demonstration of antitumor immunity.Cancer Res2001https://conductscience.org/library/papers/11431351PubMed
51495948The relationships among tumor-infiltrating lymphocytes, histopathologic findings, and long-term clinical follow-up in renal cell carcinoma.Mod Pathol1992https://conductscience.org/library/papers/1495948PubMed
611229684Inflammation and cancer: back to Virchow?Lancet2001https://conductscience.org/library/papers/11229684PubMed

Download CSV of references

Cited by84

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 136 citations.

PMIDTitleJournalYearIn PapersSource
41006825The opportunities and barriers for developing tumour-infiltrating lymphocyte therapy for patients with advanced genitourinary cancers.Nat Rev Urol2026https://conductscience.org/library/papers/41006825PubMed
40016487Neoadjuvant cabozantinib for locally advanced nonmetastatic clear cell renal cell carcinoma: a phase 2 trial.Nat Cancer2025https://conductscience.org/library/papers/40016487PubMed
39931080Uridine-cytidine kinase 2 is correlated with immune, DNA damage repair and promotion of cancer stemness in pan-cancer.Front Oncol2025https://conductscience.org/library/papers/39931080PubMed
39738081The expression of CCL17 and potential prognostic value on tumor immunity in thyroid carcinoma based on bioinformatics analysis.Sci Rep2024https://conductscience.org/library/papers/39738081PubMed
39351351Revealing the mechanisms of RAC3 in tumor aggressiveness, the immunotherapy response, and drug resistance in bladder cancer.Front Oncol2024https://conductscience.org/library/papers/39351351PubMed
39264227Prognostic value of tumor-infiltrating lymphocytes and PD-L1 expression in esophageal squamous cell carcinoma.Cancer Med2024https://conductscience.org/library/papers/39264227PubMed
38827239The Evolving Landscape of Biomarkers for Immune Checkpoint Blockade in Genitourinary Cancers.Biomark Insights2024https://conductscience.org/library/papers/38827239PubMed
38277230Identification of molecular characteristics of FUT8 and alteration of core fucosylation in kidney renal clear cell cancer.Aging (Albany NY)2024https://conductscience.org/library/papers/38277230PubMed
37496661A reactive oxygen species-related signature to predict prognosis and aid immunotherapy in clear cell renal cell carcinoma.Front Oncol2023https://conductscience.org/library/papers/37496661PubMed
37362244Tumor subtypes and signature model construction based on chromatin regulators for better prediction of prognosis in uveal melanoma.Pathol Oncol Res2023https://conductscience.org/library/papers/37362244PubMed
37277702The predictive value of CD4, CD8, and C-reactive protein in the prognosis of schistosomal and non-schistosomal colorectal cancer.BMC Gastroenterol2023https://conductscience.org/library/papers/37277702PubMed
36417422Bioinformatics analysis of immune-related prognostic genes and immunotherapy in renal clear cell carcinoma.PLoS One2022https://conductscience.org/library/papers/36417422PubMed
36389779Tumor-infiltrating lymphocytes for treatment of solid tumors: It takes two to tango?Front Immunol2022https://conductscience.org/library/papers/36389779PubMed
36253752CD4 and FOXP3 as predictive markers for the recurrence of T3/T4a stage II colorectal cancer: applying a novel discrete Bayes decision rule.BMC Cancer2022https://conductscience.org/library/papers/36253752PubMed
36077742Identification of EZH2 as Cancer Stem Cell Marker in Clear Cell Renal Cell Carcinoma and the Anti-Tumor Effect of Epigallocatechin-3-Gallate (EGCG).Cancers (Basel)2022https://conductscience.org/library/papers/36077742PubMed
35758895A Targetable Myeloid Inflammatory State Governs Disease Recurrence in Clear-Cell Renal Cell Carcinoma.Cancer Discov2022https://conductscience.org/library/papers/35758895PubMed
35485300
Everolimus (RAD001) combined with programmed death-1 (PD-1) blockade enhances radiosensitivity of cervical cancer and programmed death-ligand 1 (PD-L1) expression by blocking the phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT)/mammalian target of rapamycin (mTOR)/S6 kinase 1 (S6K1) pathway.
Bioengineered2022https://conductscience.org/library/papers/35485300PubMed
35189004CENPF as an independent prognostic and metastasis biomarker corresponding to CD4+ memory T cells in cutaneous melanoma.Cancer Sci2022https://conductscience.org/library/papers/35189004PubMed
34831452From Bench to Bedside: How the Tumor Microenvironment Is Impacting the Future of Immunotherapy for Renal Cell Carcinoma.Cells2021https://conductscience.org/library/papers/34831452PubMed
33996558Review of Prognostic Expression Markers for Clear Cell Renal Cell Carcinoma.Front Oncol2021https://conductscience.org/library/papers/33996558PubMed

See all 84 cited byDownload CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
CD8A925PubTator's text mininghttps://conductscience.org/library/genes/925NCBI Gene
TENM110178PubTator's text mininghttps://conductscience.org/library/genes/10178NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/14612901

GET https://conductscience.org/api/papers/v1/14612901/cited_by?page=2